Technology Review - Published By MIT
Advertisement
TR35

2005 Young Innovator

Paul Hergenrother, 33

University of Illinois at Urbana-Champaign

Discovering drugs that defy convention

Paul Hergenrother is a chemist who takes on huge, unsolved medical problems: antibiotic resistance, cancer, and neurodegenerative disease. His small-molecule compounds bind tightly to unconventional disease-related targets, deactivating them. For example, Hergenrother found compounds that eliminate plasmids, the DNA rings that deadly bacteria use to spread antibiotic resistance. That pioneering project led him to a general method for finding drugs that target a particular type of RNA -- messenger RNA -- as a way to silence disease-causing genes, something standard drugs cant do. Hergenrothers "ten-year vision" could lead to treatments for Alzheimers and Parkinsons.

 
 
TR35 Back to all TR35 2005 Winners   TR35 2005 Biotech Winners     
Thijn Brummelkamp
Silencing the genes that cause cancer
Martha Bulyk
Discovering how genes are regulated
Matthew DeLisa
Delivering more medicine from microbes
Kevin Eggan
Using cloning to study degenerative diseases
Paul Hergenrother
Discovering drugs that defy convention
Trey Ideker
Defining and advancing systems biology
Hang Lu
Designing microfluidic chips to study cells
Melissa Mahoney
Making materials to treat brain damage
Daniel Riskin
Developing devices for wound closure and early heart-attack intervention.
Shiladitya Sengupta
Delivering drugs to cancer cells

Comments

Advertisement
MIT Massachusetts Institute of Technology © 2010 Technology Review. All Rights Reserved.